EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors

Authors:Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W.

Used in this study: B-hEPCAM mice, B-NDG mice

Read entire article

Share:

Back to top